JPS6028931A - ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法 - Google Patents

ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法

Info

Publication number
JPS6028931A
JPS6028931A JP58136794A JP13679483A JPS6028931A JP S6028931 A JPS6028931 A JP S6028931A JP 58136794 A JP58136794 A JP 58136794A JP 13679483 A JP13679483 A JP 13679483A JP S6028931 A JPS6028931 A JP S6028931A
Authority
JP
Japan
Prior art keywords
medium
malignant tumor
tumor cell
animal
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58136794A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0361649B2 (https=
Inventor
Tomoyuki Tajima
知行 田島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Priority to JP58136794A priority Critical patent/JPS6028931A/ja
Priority to EP84305099A priority patent/EP0133029B1/en
Priority to DE8484305099T priority patent/DE3483855D1/de
Publication of JPS6028931A publication Critical patent/JPS6028931A/ja
Publication of JPH0361649B2 publication Critical patent/JPH0361649B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP58136794A 1983-07-28 1983-07-28 ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法 Granted JPS6028931A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58136794A JPS6028931A (ja) 1983-07-28 1983-07-28 ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
EP84305099A EP0133029B1 (en) 1983-07-28 1984-07-26 A process for producing inhibiting agents against proliferation of malignant tumour cells, and agents produced thereby
DE8484305099T DE3483855D1 (de) 1983-07-28 1984-07-26 Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so hergestellte mittel.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58136794A JPS6028931A (ja) 1983-07-28 1983-07-28 ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法

Publications (2)

Publication Number Publication Date
JPS6028931A true JPS6028931A (ja) 1985-02-14
JPH0361649B2 JPH0361649B2 (https=) 1991-09-20

Family

ID=15183665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58136794A Granted JPS6028931A (ja) 1983-07-28 1983-07-28 ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法

Country Status (3)

Country Link
EP (1) EP0133029B1 (https=)
JP (1) JPS6028931A (https=)
DE (1) DE3483855D1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070069A1 (ja) * 2017-10-05 2019-04-11 医療法人社団市川クリニック 殺細胞活性を有する細胞抽出成分又は組成物の調製方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS6028930A (ja) * 1983-07-28 1985-02-14 Koken Kk 人の癌由来細胞の増殖抑制剤の精製方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS59204122A (ja) * 1983-05-06 1984-11-19 Koken Kk 人の悪性腫瘍細胞増殖抑制剤の製造方法
JPS6028930A (ja) * 1983-07-28 1985-02-14 Koken Kk 人の癌由来細胞の増殖抑制剤の精製方法
JPS6043386A (ja) * 1983-08-20 1985-03-07 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070069A1 (ja) * 2017-10-05 2019-04-11 医療法人社団市川クリニック 殺細胞活性を有する細胞抽出成分又は組成物の調製方法

Also Published As

Publication number Publication date
JPH0361649B2 (https=) 1991-09-20
EP0133029B1 (en) 1990-12-27
DE3483855D1 (de) 1991-02-07
EP0133029A3 (en) 1986-08-13
EP0133029A2 (en) 1985-02-13

Similar Documents

Publication Publication Date Title
Den et al. Influence of Concanavalin A, wheat germ agglutinin, and soybean agglutinin on the fusion of myoblasts in vitro.
DK153848B (da) Fremgangsmaade til fremstilling af interferon
US4810495A (en) Agent for inhibiting proliferation of human malignant tumor cells
JPS585671B2 (ja) ヒト卵胞刺激ホルモンの製造方法
JPS603829B2 (ja) 細胞培養方法
JPS6028931A (ja) ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
Bittner et al. Survival of the mammary tumor milk agents of mice
OzAwA et al. Partial purification of a factor promoting chicken myoblast multiplication in vitro
US5135856A (en) Production of autocrine growth factors
US4595657A (en) Process for preparing an inhibiting agent against proliferation of animals malignant tumor cells
JPS6045848B2 (ja) ヒト成長ホルモンの製造方法
EP0118286B1 (en) Process for preparing an inhibiting agent
JPH0361650B2 (https=)
CN109468262A (zh) 家畜血细胞制备动物细胞培养液的方法及其制得的动物细胞培养液的应用
KR860001576B1 (ko) 인체 세포증식 촉진활성인자의 제조방법
JPS6011890B2 (ja) ツモアネクロシスフアクタ−の製造方法
Jennings et al. A growth factor from spinal cord
Deshmukh et al. Field resistance to potato blight (Phytophthora infestans)
JPS63196595A (ja) 抗腫瘍活性物質の製造方法
JPS6030656B2 (ja) ヒトｔ細胞増殖因子の製造方法
JPH04300898A (ja) 新規糖タンパク複合体およびその製造方法
JPS6028930A (ja) 人の癌由来細胞の増殖抑制剤の精製方法
JPS5816687A (ja) リンホトキシンの製造方法
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
JPS60178820A (ja) 抗腫瘍活性物質の製造方法